Representation of patients with a migration background in studies on antithrombotic treatment. An analysis of recruitment data from a cluster randomized controlled trial
| Autor: | Juliana J. Petersen, Andrea Siebenhofer, Lisa-R. Ulrich, Karola Mergenthal, Corina Guethlin, Ferdinand M. Gerlach |
|---|---|
| Přispěvatelé: | Nagler, Michael |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Male
Anticoagulant Therapy Social Sciences Geographical locations law.invention Phenprocoumon 0302 clinical medicine Randomized controlled trial law Germany Antithrombotic Medicine and Health Sciences Psychology 030212 general & internal medicine Language education.field_of_study Multidisciplinary Pharmaceutics 030503 health policy & services Anticoagulant Drugs Europe Cardiovascular Therapy Health Education and Awareness Neurology Medicine Female 0305 other medical science Research Article medicine.drug medicine.medical_specialty Patients medicine.drug_class Science Human Migration Population Disease cluster 03 medical and health sciences Fibrinolytic Agents Drug Therapy Internal medicine Mental Health and Psychiatry medicine Humans European Union ddc:610 education Primary Care Aged Demography Pharmacology business.industry Patient Selection Cognitive Psychology Warfarin Anticoagulants Biology and Life Sciences Health Care Sample size determination Cognitive Science Dementia People and places business Neuroscience |
| Zdroj: | PLoS ONE PLoS ONE, Vol 15, Iss 3, p e0230297 (2020) |
| Popis: | Background: The health status, health awareness and health behavior of persons with a migration background often differ from the autochthonous population. Little is known about the proportion of patients with a migration background (PMB) that participate in primary care studies on oral antithrombotic treatment (OAT) in Germany, and whether the quality of their antithrombotic care differs from patients without a migration background. The aim of this paper was to use the results of a cluster-randomized controlled trial (PICANT) to determine the proportion of PMB at different stages of recruitment, and to compare the results in terms of sociodemographic characteristics and antithrombotic treatment. Methods: This study used screening and baseline data from the PICANT trial on oral anticoagulation management in GP practices. For this analysis, we determined the proportion of PMB during the recruitment period at stage 1 (screening of potentially eligible patients), stage 2 (eligible patients invited to participate in the trial), and stage 3 (assessment of baseline characteristics of patients participating in the PICANT trial). In addition, we compared patients in terms of sociodemographic characteristics and quality of anticoagulant treatment. Statistical analysis comprised descriptive and bivariate analyses. Results: The proportion of PMB at each recruitment stage declined from 9.1% at stage 1 to 7.9% at stage 2 and 7.3% at stage 3). A lack of German language skills led to the exclusion of half the otherwise eligible PMB. At stages 1 and 3, PMB were younger (stage 1: 70.7 vs. 75.0 years, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|